{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T22:28:04Z","timestamp":1768256884044,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.clinthera.2008.05.017","type":"journal-article","created":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T08:37:29Z","timestamp":1216456649000},"page":"1089-1101","source":"Crossref","is-referenced-by-count":82,"title":["A 52-Week, Randomized, Open-Label, Parallel-Group Comparison of the Tolerability and Effects of Pitavastatin and Atorvastatin on High-Density Lipoprotein Cholesterol Levels and Glucose Metabolism in Japanese Patients with Elevated Levels of Low-Density Lipoprotein Cholesterol and Glucose Intolerance"],"prefix":"10.1016","volume":"30","author":[{"given":"Jun","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadanobu","family":"Kuribayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keizou","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadatoshi","family":"Biro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyosuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Ageta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syozou","family":"Kobori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsunori","family":"Saikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Otonari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suminori","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.05.017_bib1","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1001\/jama.1987.03390160062027","article-title":"Cholesterol and mortality. 30 Years of follow-up from the Framingham Study","volume":"257","author":"Anderson","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.05.017_bib2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.05.017_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.05.017_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.05.017_bib6","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.05.017_bib7","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.05.017_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199907083410202","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib11","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: A randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.05.017_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2008.05.017_bib15","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: The IDEAL study: A randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.05.017_bib16","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1172\/JCI30163","article-title":"Molecular regulation of HDL metabolism and function: Implications for novel therapies","volume":"116","author":"Rader","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2008.05.017_bib17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jama.298.7.786","article-title":"High-density lipoprotein as a therapeutic target: A systematic review","volume":"298","author":"Singh","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.05.017_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.05.017_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: From basic research to clinical practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2008.05.017_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/diacare.28.1.101","article-title":"Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?","volume":"28","author":"Drexel","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2008.05.017_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2008.05.017_bib23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.clinthera.2005.07.007","article-title":"A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia","volume":"27","author":"Park","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2008.05.017_bib24","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.2337\/diacare.28.12.2980-a","article-title":"Efficacy of pitavastatin, a new HMG-CoA reductase inhibitor, on lipid and glucose metabolism in patients with type 2 diabetes","volume":"28","author":"Kawai","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2008.05.017_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1742-1241.2005.00461.x","article-title":"Pitavastatin","volume":"59","author":"Mukhtar","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2008.05.017_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3466.2003.tb00116.x","article-title":"Pitavastatin: Efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor","volume":"21","author":"Kajinami","year":"2003","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.clinthera.2008.05.017_bib27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0021-9150(01)00765-1","article-title":"Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia","volume":"163","author":"Noji","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2008.05.017_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5551\/jat.13.108","article-title":"Efficacy of a low dose of pitavastatin compared with atorvastatin in primary hyperlipidemia: Results of a 12-week, open label study","volume":"13","author":"Yoshitomi","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.clinthera.2008.05.017_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5551\/jat.13.123","article-title":"Statins: Beneficial or adverse for glucose metabolism","volume":"13","author":"Sasaki","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.clinthera.2008.05.017_bib30","series-title":"Japan Diabetes Society Guideline for Treatment of Diabetes Mellitus 2006-2007","year":"2006"},{"key":"10.1016\/j.clinthera.2008.05.017_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/clinchem\/19.12.1350","article-title":"Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum","volume":"19","author":"Richmond","year":"1973","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2008.05.017_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/clinchem\/19.5.476","article-title":"Quantitative determination of serum triglycerides by the use of enzymes","volume":"19","author":"Bucolo","year":"1973","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2008.05.017_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jcla.10101","article-title":"New homogeneous HDL-cholesterol assay without the influence of high TG sample using the selective detergent to lipoproteins","volume":"17","author":"Ueda","year":"2003","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.clinthera.2008.05.017_bib37","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/clinchem\/44.6.1242","article-title":"Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method","volume":"44","author":"Rifai","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2008.05.017_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0009-8981(01)00591-5","article-title":"Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level","volume":"312","author":"Sakurabayashi","year":"2001","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clinthera.2008.05.017_bib39","first-page":"101","article-title":"A glucose dehydrogenase for the determination of glucose concentrations in body fluids [in German]","volume":"13","author":"Banauch","year":"1975","journal-title":"Z Klin Chem Klin Biochem"},{"key":"10.1016\/j.clinthera.2008.05.017_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2008.05.017_bib41","first-page":"885","article-title":"Clinical safety and efficacy of NK-104 (pitavastatin), a new synthetic HMG-CoA reductase inhibitor, in the long-term treatment of hyperlipidemia: Results of a multicenter long-term study [in Japanese, with abstract in English]","volume":"17","author":"Teramoto","year":"2001","journal-title":"Rinshoiyaku"},{"key":"10.1016\/j.clinthera.2008.05.017_bib42","first-page":"2123","article-title":"Clinical efficacy of long-term treatment with CI-981 (atorvastatin), a new synthetic HMG-CoA reductase inhibitor [in Japanese]","volume":"19","year":"1999","journal-title":"Prog Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib43","series-title":"Practical Statistics for Medical Research","author":"Altman","year":"1991"},{"key":"10.1016\/j.clinthera.2008.05.017_bib44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.297.5.499","article-title":"Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis","volume":"297","author":"Nicholls","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.05.017_bib45","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.017_bib46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-2918(01)80073-4","article-title":"Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia","volume":"23","author":"Branchi","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2008.05.017_bib47","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T15:08:50Z","timestamp":1584112130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0149291808001872"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.05.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}